-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NmAzYc6xNos0tfpa8T3GZWaR4rTJOS+OMjepzDB1T+tWOSlJ67UjUKSnwrCmJw7e Z0X3EwwC1lDInKhfqOSl0Q== 0001209191-07-006904.txt : 20070201 0001209191-07-006904.hdr.sgml : 20070201 20070201192158 ACCESSION NUMBER: 0001209191-07-006904 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070126 FILED AS OF DATE: 20070201 DATE AS OF CHANGE: 20070201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: West John CENTRAL INDEX KEY: 0001320337 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 07573303 BUSINESS ADDRESS: BUSINESS PHONE: 510-670-9300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 4/A 1 bsf26824_bsf14jw.xml MAIN DOCUMENT DESCRIPTION X0202 4/A 2007-01-26 2007-01-30 1 0000913275 Solexa, Inc. SLXA 0001320337 West John C/O SOLEXA, INC. 25861 INDUSTRIAL BLVD. HAYWARD CA 94545 1 1 0 0 CEO Stock Option (Right to Buy) 1.28 2007-01-26 4 D 0 309253 0.00 D 2014-08-06 Common Stock 309253 0 D Stock Option (Right to Buy) 6.39 2007-01-26 4 D 0 600000 0.00 D 2015-05-09 Common Stock 600000 0 D This option, which provided for vesting of 25% on the one year anniversary of August 6, 2004 and monthly thereafter over 36 months, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 106,383 shares at an exercise price of $3.72 per share. In connection with the closing of the merger on January 26, 2007, the vesting and exercisability of this option was accelerated by 2 years as provided in the employment agreement between the Issuer and the Reporting Person. This option, which provided for vesting monthly and ratably over the 48 month period beginning on August 9, 2004, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 206,400 shares at an exercise price of $18.58 per share. In connection with the closing of the merger on January 26, 2007, the vesting and exercisability of this option was accelerated by 2 years as provided in the employment agreement between the Issuer and the Reporting Person. /s/ John West 2007-02-01 -----END PRIVACY-ENHANCED MESSAGE-----